LGALS3 and COVID-19: Although a link between galectin-3 and the clinical course of COVID-19 has been reported in a few studies [12,13], to the best of our knowledge, this is the first report verifying this association in patient cohorts from two different centers, therefore strengthening the notion that galectin-3 is an important mediator in COVID-19 progression.